FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293125100> ?p ?o ?g. }

• W4293125100 endingPage "286" @default.
• W4293125100 startingPage "280" @default.
• W4293125100 abstract "Introduction: Perioperative alterations in perfusion lead to ischemia and reperfusion injury, and supplemental oxygen is administered during surgery to limit hypoxic injury but can lead to hyperoxia. We hypothesized that hyperoxia impairs endothelium-dependent and endothelium-independent vasodilation but not the vasodilatory response to heme-independent soluble guanylyl cyclase activation. Methods: We measured the effect of oxygen on vascular reactivity in mouse aortas. Mice were ventilated with 21% (normoxia), 60% (moderate hyperoxia), or 100% (severe hyperoxia) oxygen during 30 minutes of renal ischemia and 30 minutes of reperfusion. After sacrifice, the thoracic aorta was isolated, and segments mounted on a wire myograph. We measured endothelium-dependent and endothelium-independent vasodilation with escalating concentrations of acetylcholine (ACh) and sodium nitroprusside (SNP), respectively, and we measured the response to heme-independent soluble guanylyl cyclase activation with cinaciguat. Vasodilator responses to each agonist were quantified as the maximal theoretical response ( Emax ) and the effective concentration to elicit 50% relaxation (EC 50 ) using a sigmoid model and nonlinear mixed-effects regression. Aortic superoxide was measured with dihydroethidium probe and high-performance liquid chromatography quantification of the specific superoxide product 2-hydroxyethidium. Results: Hyperoxia impaired endothelium-dependent (ACh) and endothelium-independent (SNP) vasodilation compared with normoxia and had no effect on cinaciguat-induced vasodilation. The median ACh Emax was 76.4% (95% confidence interval = 69.6 to 83.3) in the normoxia group, 53.5% (46.7 to 60.3) in the moderate hyperoxia group, and 53.1% (46.3 to 60.0) in the severe hyperoxia group ( P < 0.001, effect across groups), while the ACh EC 50 was not different among groups. The SNP Emax was 133.1% (122.9 to 143.3) in normoxia, 128.3% (118.1 to 138.6) in moderate hyperoxia, and 114.8% (104.6 to 125.0) in severe hyperoxia ( P < 0.001, effect across groups), and the SNP EC 50 was 0.38 log M greater in moderate hyperoxia than in normoxia (95% confidence interval = 0.18 to 0.58, P < 0.001). Cinaciguat Emax and EC 50 were not different among oxygen treatment groups (median range Emax = 78.0% to 79.4% and EC 50 = -18.0 to -18.2 log M across oxygen groups). Aorta 2-hydroxyethidium was 1419 pmol/mg of protein (25th-75th percentile = 1178-1513) in normoxia, 1993 (1831-2473) in moderate hyperoxia, and 2078 (1936-2922) in severe hyperoxia ( P = 0.008, effect across groups). Conclusions: Hyperoxia, compared with normoxia, impaired endothelium-dependent and endothelium-independent vasodilation but not the response to heme-independent soluble guanylyl cyclase activation, and hyperoxia increased vascular superoxide production. Results from this study could have important implications for patients receiving high concentrations of oxygen and at risk for ischemia reperfusion-mediated organ injury." @default.
• W4293125100 created "2022-08-26" @default.
• W4293125100 creator A5002181030 @default.
• W4293125100 creator A5015504359 @default.
• W4293125100 creator A5017233678 @default.
• W4293125100 creator A5022383180 @default.
• W4293125100 creator A5045851256 @default.
• W4293125100 creator A5057394210 @default.
• W4293125100 creator A5064111917 @default.
• W4293125100 creator A5086468930 @default.
• W4293125100 date "2022-08-16" @default.
• W4293125100 modified "2023-10-03" @default.
• W4293125100 title "SOLUBLE GUANYLYL CYCLASE ACTIVATION RESCUES HYPEROXIA-INDUCED DYSFUNCTION OF VASCULAR RELAXATION" @default.
• W4293125100 cites W1956277079 @default.
• W4293125100 cites W1965759481 @default.
• W4293125100 cites W1997023449 @default.
• W4293125100 cites W2032832927 @default.
• W4293125100 cites W2039093830 @default.
• W4293125100 cites W2102634173 @default.
• W4293125100 cites W2106120395 @default.
• W4293125100 cites W2107267411 @default.
• W4293125100 cites W2113297587 @default.
• W4293125100 cites W2114297749 @default.
• W4293125100 cites W2115993532 @default.
• W4293125100 cites W2138355641 @default.
• W4293125100 cites W2145983726 @default.
• W4293125100 cites W2147908723 @default.
• W4293125100 cites W2162583612 @default.
• W4293125100 cites W2166046639 @default.
• W4293125100 cites W2168961368 @default.
• W4293125100 cites W2371948111 @default.
• W4293125100 cites W2743090782 @default.
• W4293125100 cites W2789526006 @default.
• W4293125100 cites W3092593534 @default.
• W4293125100 cites W3120249407 @default.
• W4293125100 cites W3164215215 @default.
• W4293125100 cites W3189270851 @default.
• W4293125100 doi "https://doi.org/10.1097/shk.0000000000001982" @default.
• W4293125100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36018251" @default.
• W4293125100 hasPublicationYear "2022" @default.
• W4293125100 type Work @default.
• W4293125100 citedByCount "2" @default.
• W4293125100 countsByYear W42931251002023 @default.
• W4293125100 crossrefType "journal-article" @default.
• W4293125100 hasAuthorship W4293125100A5002181030 @default.
• W4293125100 hasAuthorship W4293125100A5015504359 @default.
• W4293125100 hasAuthorship W4293125100A5017233678 @default.
• W4293125100 hasAuthorship W4293125100A5022383180 @default.
• W4293125100 hasAuthorship W4293125100A5045851256 @default.
• W4293125100 hasAuthorship W4293125100A5057394210 @default.
• W4293125100 hasAuthorship W4293125100A5064111917 @default.
• W4293125100 hasAuthorship W4293125100A5086468930 @default.
• W4293125100 hasConcept C120770815 @default.
• W4293125100 hasConcept C126322002 @default.
• W4293125100 hasConcept C134018914 @default.
• W4293125100 hasConcept C173803235 @default.
• W4293125100 hasConcept C185592680 @default.
• W4293125100 hasConcept C2776992346 @default.
• W4293125100 hasConcept C2777714996 @default.
• W4293125100 hasConcept C2778827303 @default.
• W4293125100 hasConcept C2779610285 @default.
• W4293125100 hasConcept C2780672939 @default.
• W4293125100 hasConcept C42219234 @default.
• W4293125100 hasConcept C519581460 @default.
• W4293125100 hasConcept C541997718 @default.
• W4293125100 hasConcept C71924100 @default.
• W4293125100 hasConcept C98274493 @default.
• W4293125100 hasConceptScore W4293125100C120770815 @default.
• W4293125100 hasConceptScore W4293125100C126322002 @default.
• W4293125100 hasConceptScore W4293125100C134018914 @default.
• W4293125100 hasConceptScore W4293125100C173803235 @default.
• W4293125100 hasConceptScore W4293125100C185592680 @default.
• W4293125100 hasConceptScore W4293125100C2776992346 @default.
• W4293125100 hasConceptScore W4293125100C2777714996 @default.
• W4293125100 hasConceptScore W4293125100C2778827303 @default.
• W4293125100 hasConceptScore W4293125100C2779610285 @default.
• W4293125100 hasConceptScore W4293125100C2780672939 @default.
• W4293125100 hasConceptScore W4293125100C42219234 @default.
• W4293125100 hasConceptScore W4293125100C519581460 @default.
• W4293125100 hasConceptScore W4293125100C541997718 @default.
• W4293125100 hasConceptScore W4293125100C71924100 @default.
• W4293125100 hasConceptScore W4293125100C98274493 @default.
• W4293125100 hasIssue "4" @default.
• W4293125100 hasLocation W42931251001 @default.
• W4293125100 hasLocation W42931251002 @default.
• W4293125100 hasOpenAccess W4293125100 @default.
• W4293125100 hasPrimaryLocation W42931251001 @default.
• W4293125100 hasRelatedWork W113972090 @default.
• W4293125100 hasRelatedWork W2029984904 @default.
• W4293125100 hasRelatedWork W2031008864 @default.
• W4293125100 hasRelatedWork W2041697601 @default.
• W4293125100 hasRelatedWork W2161966493 @default.
• W4293125100 hasRelatedWork W2318074237 @default.
• W4293125100 hasRelatedWork W2748952813 @default.
• W4293125100 hasRelatedWork W2987945590 @default.
• W4293125100 hasRelatedWork W3143127457 @default.
• W4293125100 hasRelatedWork W3144812207 @default.
• W4293125100 hasVolume "58" @default.

• next